ACH
MGNX icon

ArrowMark Colorado Holdings’s MacroGenics MGNX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,382
Closed -$41K – 384
2016
Q3 		$41K Buy
+1,382
New +$41.1K ﹤0.01% 305

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ArrowMark Colorado Holdings's MGNX Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of MacroGenics (MGNX) in Q4 2016, closing a stake of 1,382 shares — an estimated $41K sold.

ArrowMark Colorado Holdings first reported a position in MGNX in Q3 2016 and held it in 1 quarter. The position peaked at $41K in Q3 2016. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

  • ArrowMark Colorado Holdings reported no remaining MacroGenics position as of Q4 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 1,382 MacroGenics shares in Q4 2016, an estimated $41K.
  • ArrowMark Colorado Holdings first reported a position in MacroGenics in Q3 2016 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's MacroGenics position peaked at $41K in Q3 2016.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.